Clinical Trial Update: Association of L-asparaginase-Methotrexate-Dexamethasone for Nasal and Nasal-type Natural Killer (NK)-T-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating L-asparaginase, methotrexate, and dexamethasone for nasal and nasal-type natural killer/T-cell lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Natural Killer T-cell Lymphoma Nasal Type

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• L-asparaginase (L-asparaginase)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: University Hospital, Limoges | Conditions: Lymphoma, Non-Hodgkin | Phase 2 | Status: COMPLETED